From: Gut microbial determinants of clinically important improvement in patients with rheumatoid arthritis
Patient characteristicsφ | Marginal model | Adjusted model | ||
---|---|---|---|---|
Variance (%) | P value# | Variance (%) | P value# | |
Age group | 7.7 | 0.001 | 7.7 | 0.001 |
MCII patient group | 4.4 | 0.003 | 3.8 | 0.002 |
csDMARDs | 3.7 | 0.008 | 3.1 | 0.008 |
Sex | 3.1 | 0.024 | 2.9 | 0.013 |
Smoking status | 4.0 | 0.009 | 2.7 | 0.028 |
CDAI | 2.3 | 0.120 | 2.3 | 0.056 |
bDMARDs | 1.8 | 0.324 | 1.6 | 0.280 |
Prednisone | 1.7 | 0.350 | 1.6 | 0.284 |